KORU Medical Systems shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 revenue guidance above estimates. Also, Piper Sandler maintained an Overweight rating on the stock and raised its price target from $2.5 to $3.
Portfolio Pulse from Benzinga Newsdesk
KORU Medical Systems shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 revenue guidance above estimates. Piper Sandler maintained an Overweight rating on the stock and raised its price target from $2.5 to $3.
August 08, 2024 | 4:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
KORU Medical Systems shares are trading higher due to better-than-expected Q2 financial results and an increase in FY24 revenue guidance. Piper Sandler also raised its price target from $2.5 to $3 while maintaining an Overweight rating.
The better-than-expected Q2 financial results and raised FY24 revenue guidance are positive indicators for the company's future performance. Additionally, Piper Sandler's maintained Overweight rating and increased price target further boost investor confidence.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100